← SynDRA
HALCINONIDE
SynDRA canonical compound SYN0023231 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | NR3C1 |
|---|
| Mechanism of action | Glucocorticoid receptor agonist |
|---|
| Indication | corticosteroid-responsive dermatoses |
|---|
| Disease area | dermatology |
|---|
All known targets
- NR3C1
- Ar
- ESRRA
- ESRRB
- ESRRG
- PGR
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- ACHE
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KDR
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- GLP1R
- NFE2L2
- NPY1R
- NPY2R
- SAMHD1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SIGMAR1
- PTPRC
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CFTR
- CP2C9
- CP2CJ
- CP3A7
- GLI3
- KSYK
- NR1I2
- PRGR
- RARA
- RXFP1
- SYK
Drug classes
- Corticosteroid Hormone Receptor Agonists
- Corticosteroid
- Anti-Inflammatory Agents
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
Cross-references
Synonyms
- HALOG
- HALOG-E
- Halog
- alcinonide
- halciderm
- halcimat
- halog
- Halcinonida
- NSC-758413
- SO-18566
- SQ-18566
- Halog-e
- Halciderm
- Halcimat
- SI86V6QNEG
- Halcort
- NSC 758413
- SO 18566
- SQ-18,566
- Betacorton
- Halcinonidum
- Ascochrom
- Volog
- UNII-SI86V6QNEG
- Halcinonidum [INN-Latin]
- Halcinonida [INN-Spanish]
- NCGC00016621-01
- CAS-3093-35-4
- EINECS 221-439-6
- Prestwick_1069
- Halog (TN)
- BRN 1358242
- Halcinonide [USAN:USP:INN:BAN:JAN]
- HALCINONIDE [MI]
- Prestwick0_000655
- Prestwick1_000655
- Prestwick2_000655
Look up HALCINONIDE in the interactive SynDRA portal →